title: Remarkable regression of malignant paraganglioma in the retroperitoneum and neck after chemotherapy: report of a case and a review of the literature.
abstract: The present communication describes a patient with paraganglioma found in the retroperitoneum and neck. She was treated with the combination chemotherapy employing cyclophosphamide, doxorubicin, and cisplatin (CAP therapy), and resulted in remarkable regression of the tumor in size. We reviewed the literature about the therapy of paraganglioma and the nature of retroperitoneal paraganglioma in relation with this case.
authors: Department of Clinical Pathology, Tokyo Medical College, Japan.
authors: K
authors: K
authors: Koshihara
authors: I
authors: I
authors: Komiya
authors: M
authors: M
authors: Watanabe
authors: M
authors: M
authors: Maeda
authors: N
authors: N
authors: Fukushima
authors: Y
authors: Y
authors: Hoshihara
authors: Y
authors: Y
authors: Saito
mesh_terms: D015250:Aclarubicin / Q000008:administration & dosage; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D010235:Paraganglioma / Q000175:diagnosis / Q000188:drug therapy*; D017663:Peplomycin; D012186:Retroperitoneal Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
chemical_list: D001761:Bleomycin; D017663:Peplomycin; D015250:Aclarubicin; D002945:Cisplatin